Nitanap 500 Tablet contains Nitazoxanide 500mg, a broad-spectrum antiprotozoal and antimicrobial agent indicated for the treatment of gastrointestinal protozoal infections such as giardiasis, amoebiasis, and other parasitic infections. It helps in reducing parasite load and alleviating associated symptoms.
Nitazoxanide works by interfering with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transfer reaction essential for anaerobic energy metabolism in protozoa and anaerobic bacteria, effectively eliminating the pathogen.
For distributors and healthcare suppliers, Nitanap 500 Tablet is a high-demand gastrointestinal therapy product, commonly used in hospitals, clinics, and outpatient care. The persistent prevalence of parasitic infections ensures stable and continuous market demand.
Adding Nitanap 500 Tablet to your antiprotozoal and antimicrobial therapy segment creates strong opportunities in pharmacies, hospitals, travel clinics, export markets, and third-party manufacturing. Its proven efficacy, broad therapeutic coverage, and prescriber trust make it a valuable addition to pharmaceutical distribution portfolios.